BAKER BROS. ADVISORS LP

Holdings History for Replimune Group, Inc. - Common Stock, par value $0.001 per share (REPL)

Symbol: REPL on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 11,045,336 shares
Security Ownership %: 14%

Shares, Excluding Options vs Price

Value, Excluding Options

Baker Bros. Advisors LP ownership in Replimune Group, Inc. Common Stock, par value $0.001 per share (REPL)

07 Mar 2025 - Baker Bros. Advisors LP has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,045,336 shares of Replimune Group, Inc. Common Stock, par value $0.001 per share (REPL). This represents 14% ownership of the company. This is the first filing by BAKER BROS. ADVISORS LP disclosing ownership of Replimune Group, Inc. Common Stock, par value $0.001 per share (REPL).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Baker Bros. Advisors LP	14%		$99,960,291	11,045,336			$9.05	13D	07 Mar 2025	07 Mar 2025, 17:07

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.63%	0%	$107,360,666	11,045,336	0		$9.72	Q4 2025
30 Sep 2025	0.33%	0%	$46,279,958	11,045,336	0		$4.19	Q3 2025
30 Jun 2025	1%	0%	$102,611,171	11,045,336	0		$9.29	Q2 2025
31 Mar 2025	1.2%	0%	$107,692,026	11,045,336	0		$9.75	Q1 2025
31 Dec 2024	1.4%	0%	$133,759,019	11,045,336	0		$12.11	Q4 2024
30 Sep 2024	1.3%	+0.11%	$121,056,883	11,045,336	+1,000,000	+10%	$10.96	Q3 2024
30 Jun 2024	1.2%	+0.06%	$90,408,024	10,045,336	+500,000	+5.2%	$9.00	Q2 2024
31 Mar 2024	0.98%	0%	$77,985,395	9,545,336	0		$8.17	Q1 2024
31 Dec 2023	0.92%	+0.48%	$80,467,182	9,545,336	+4,967,056	+108%	$8.43	Q4 2023
30 Sep 2023	0.45%	0%	$78,334,371	4,578,280	0		$17.11	Q3 2023
30 Jun 2023	0.62%	0%	$106,307,662	4,578,280	0		$23.22	Q2 2023
31 Mar 2023	0.44%	0%	$80,852,425	4,578,280	0		$17.66	Q1 2023
31 Dec 2022	0.75%	+0.11%	$124,529,216	4,578,280	+684,437	+18%	$27.20	Q4 2022
30 Sep 2022	0.44%	+0.03%	$67,247,000	3,893,843	+302,762	+8.4%	$17.27	Q3 2022
30 Jun 2022	0.36%	+0.2%	$62,772,000	3,591,081	+1,979,378	+123%	$17.48	Q2 2022
31 Mar 2022	0.16%	+0.1%	$27,367,000	1,611,703	+1,018,308	+172%	$16.98	Q1 2022
31 Dec 2021	0.08%	+0.06%	$16,081,000	593,395	+439,883	+287%	$27.10	Q4 2021
30 Sep 2021	0.02%	0%	$4,550,000	153,512	0		$29.64	Q3 2021
30 Jun 2021	0.03%	0%	$5,898,000	153,512	0		$38.42	Q2 2021
31 Mar 2021	0.02%	0%	$4,684,000	153,512	0		$30.51	Q1 2021
31 Dec 2020	0.02%	-0.01%	$5,856,000	153,512	-53,074	-26%	$38.15	Q4 2020
30 Sep 2020	0.02%	+0.02%	$4,756,000	206,586	+201,445	+3918%	$23.02	Q3 2020
30 Jun 2020	0%	+0%	$128,000	5,141	+5,141	NEW	$24.90	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.